Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Rallybio Q2 EPS $(0.22) Beats $(0.24) Estimate, Sales $212.000K Down From $299.000K YoY

Author: Benzinga Newsdesk | August 07, 2025 07:09am
Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.24) by 10.2 percent. This is a 40.54 percent increase over losses of $(0.37) per share from the same period last year. The company reported $212.000 thousand in sales this quarter. This is a 29.10 percent decrease over sales of $299.000 thousand the same period last year.

Posted In: RLYB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist